AAX Biotech to present a poster at PEGS Boston 2026

We are excited to share that our Head of R&D, Ionut Gabriel Dumitru, PhD, will be representing AAX Biotech at the 22nd Annual PEGS Boston on May 11-15. 

Ionut will be presenting a poster on Opti-mAb®, our breakthrough technology designed to solve one of the most persistent challenges in antibody therapeutics: scFv instability. 

scFv antibodies are used in rapidly growing therapeutic areas, including CAR-Ts and bispecific antibodies. Yet, their inherent instability leads to high development costs and limits therapeutic performance. Opti-mAb® addresses this by significantly improving both production yields and stability of scFv antibodies. 

Ionut will also be discussing Seqitope®, our high-resolution and high-throughput epitope mapping technology that accelerates antibody discovery and de-risks lead candidate selection.  

Find us at our poster #209704: “Opti-mAb®: a novel scFv format for improved therapies.” 

Will you be in Boston? Let us know or connect directly with Ionut!